| Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor J Maher, RJ Brentjens, G Gunset, I Rivière, M Sadelain Nature biotechnology 20 (1), 70-75, 2002 | 1258 | 2002 |
| Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling S Wilkie, MCI van Schalkwyk, S Hobbs, DM Davies, SJC van der Stegen, ... Journal of clinical immunology 32, 1059-1070, 2012 | 516 | 2012 |
| Nucleic acids encoding chimeric T cell receptors M Sadelain, R Brentjens, J Maher US Patent 7,446,190, 2008 | 449 | 2008 |
| Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor S Wilkie, G Picco, J Foster, DM Davies, S Julien, L Cooper, S Arif, ... The Journal of Immunology 180 (7), 4901-4909, 2008 | 418 | 2008 |
| Antibody response to SARS-CoV-2 infection in humans: A systematic review N Post, D Eddy, C Huntley, MCI Van Schalkwyk, M Shrotri, D Leeman, ... PloS one 15 (12), e0244126, 2020 | 397 | 2020 |
| Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection DA Boardman, C Philippeos, GO Fruhwirth, MAA Ibrahim, RF Hannen, ... American Journal of Transplantation 17 (4), 931-943, 2017 | 302 | 2017 |
| The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9 R Beatson, V Tajadura-Ortega, D Achkova, G Picco, TD Tsourouktsoglou, ... Nature immunology 17 (11), 1273-1281, 2016 | 292 | 2016 |
| Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4 S Wilkie, SE Burbridge, L Chiapero-Stanke, ACP Pereira, S Cleary, ... Journal of Biological Chemistry 285 (33), 25538-25544, 2010 | 209 | 2010 |
| Strategies to address chimeric antigen receptor tonic signaling A Ajina, J Maher Molecular cancer therapeutics 17 (9), 1795-1815, 2018 | 184 | 2018 |
| CAR T-cells targeting the integrin αvβ6 and co-expressing the chemokine receptor CXCR2 demonstrate enhanced homing and efficacy against several solid malignancies LM Whilding, L Halim, B Draper, AC Parente-Pereira, T Zabinski, ... Cancers 11 (5), 674, 2019 | 152 | 2019 |
| Ovarian cancer immunotherapy using PD‐L1 siRNA targeted delivery from folic acid‐functionalized polyethylenimine: strategies to enhance T cell killing PY Teo, C Yang, LM Whilding, AC Parente‐Pereira, J Maher, AJT George, ... Advanced healthcare materials 4 (8), 1180-1189, 2015 | 152 | 2015 |
| Targeting cytotoxic T lymphocytes for cancer immunotherapy J Maher, ET Davies British journal of cancer 91 (5), 817-821, 2004 | 152 | 2004 |
| CAR T cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth R Zhou, M Yazdanifar, LD Roy, LM Whilding, A Gavrill, J Maher, ... Frontiers in immunology 10, 1149, 2019 | 148 | 2019 |
| T cell response to SARS-CoV-2 infection in humans: A systematic review M Shrotri, MCI van Schalkwyk, N Post, D Eddy, C Huntley, D Leeman, ... PloS one 16 (1), e0245532, 2021 | 136 | 2021 |
| Design of a phase I clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer MCI van Schalkwyk, SE Papa, JP Jeannon, TG Urbano, JF Spicer, ... Human gene therapy clinical development 24 (3), 134-142, 2013 | 134 | 2013 |
| Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice AC Parente-Pereira, J Burnet, D Ellison, J Foster, DM Davies, ... Journal of clinical immunology 31, 710-718, 2011 | 133 | 2011 |
| Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? SJC Van der Stegen, DM Davies, S Wilkie, J Foster, JK Sosabowski, ... The Journal of Immunology 191 (9), 4589-4598, 2013 | 128 | 2013 |
| Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells DM Davies, J Foster, SJC Van Der Stegen, AC Parente-Pereira, ... Molecular medicine 18, 565-576, 2012 | 122 | 2012 |
| Enhanced anti-lymphoma activity of CAR19-iNKT cells underpinned by dual CD19 and CD1d targeting A Rotolo, VS Caputo, M Holubova, N Baxan, O Dubois, MS Chaudhry, ... Cancer Cell 34 (4), 596-610. e11, 2018 | 121 | 2018 |
| The role of the interleukin (IL)-6/IL-6 receptor axis in cancer MY Taher, DM Davies, J Maher Biochemical Society Transactions 46 (6), 1449-1462, 2018 | 118 | 2018 |
